Breast Cancer Caregiver Survey: Women Being Treated with Herceptin-Perjeta Combination Therapy
The pan-Canadian Oncology Drug Review (pCODR) makes recommendations about whether the provincial health plans should pay for new cancer drugs. pCODR will soon be reviewing the use of Herceptin-Perjeta combination...
Read More







